Rapport Therapeutics Earnings
NASDAQ: RAPPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 3:17 PM ET
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.21
Rapport Therapeutics earnings summary
Rapport Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-1.21. In its most recent report on Aug 5, 2026 (Q2 2026), RAPP posted EPS of $-1.19. Revenue for the quarter was $0.
Across the last 9 reports, RAPP shares moved an average of 6.3% (in either direction) in the first trading session after results, rising 3 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
RAPP earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-1.19 | — | +4.2% |
| May 7, 2026 | — | $-0.42 | — | -2.5% |
| Mar 10, 2026 | — | $-0.72 | — | -2.7% |
| Nov 6, 2025 | — | $-0.71 | — | -5.0% |
| Aug 7, 2025 | — | $-0.75 | — | +1.1% |
| May 8, 2025 | — | $-0.68 | — | -2.8% |
| Mar 11, 2025 | — | $9.49 | — | -7.5% |
| Nov 7, 2024 | — | $-0.50 | — | -21.5% |
| Aug 8, 2024 | — | $-1.70 | — | +9.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.